BMRA241220P5000
- 0.00
- 0.000.00%
Biomerica Newsroom
Sector Update: Health Care Stocks Climb Thursday Afternoon
Express News | Biomerica Inc: Patents Secured Apply to Countries Under European Patent Organization
Express News | Biomerica Secures Three Key International Patents for Infoods® Technology to Address Gerd, Crohn’s Disease, and Ulcerative Colitis
Biomerica Secures Three Key International Patents for InFoods Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis
Express News | Nasdaq Grants Biomerica an Additional 180 Days to Meet Listing Compliance Requirements
12 Health Care Stocks Moving In Friday's After-Market Session
Biomerica Shares Are Trading Higher After the Company Announced the Direct-to-consumer Availability of InFoods Tests on InFoods Sites.
Biomerica Gains on IBS Announcement
Biomerica Announces Direct-to-Consumer Availability of InFoods IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain
Biomerica | 10-Q: Q1 2025 Earnings Report
Express News | Biomerica Shares Are Trading Higher After the Company Announced Its 10-minute At-home PSA Test for Early Prostate Cancer Detection Was Approved by the Saudi FDA
The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer
Express News | Biomerica Q4 EPS $(0.09) Up From $(0.10) YoY, Sales $1.12M Up From $1.11M YoY
Biomerica FY24 Rev $5.4M >BMRA
Biomerica Reports Fiscal 2024 Year End Results
Press Release: Biomerica Reports Fiscal 2024 Year End Results
Biomerica | 10-K: FY2024 Annual Report
Biomerica Launches At-Home Sample Collection for InFoods IBS, Significantly Expanding Access for Millions of IBS Sufferers
Express News | Biomerica Inc - on June 26 Jack Kenny Notified Biomerica of His Resignation as Company's Chairman of Board
12 Health Care Stocks Moving In Thursday's After-Market Session